Trial Profile
A phase II trial to investigate the efficacy of CYT-6091 in lung cancer patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2014
Price :
$35
*
At a glance
- Drugs CYT 6091 (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 13 Nov 2014 New trial record